OPHIREX, INC

Federal contract awards won by OPHIREX, INC (UEI W452WY5E2JQ9), 2020–2023 — public record from USAspending.

Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

4

awards

$35,106,490

total value

1

agency

Agencies buying from OPHIREX, INC

Department of Defense (4)

What OPHIREX, INC sells

541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (4)

Awards

DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510

Department of Defense · $1,299,779 · Aug 25, 2023

FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY

Department of Defense · $13,827,499 · Apr 5, 2022

COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV-2" LOG #19000053

Department of Defense · $10,571,594 · Jun 19, 2020

ARMY MEDICAL RESEARCH AND DEVELOPMENT SBIR PHASE III CONTRACT TITLED ADVANCEMENT OF ADVANCEMENT BROAD-SPECTRUM SNAKEBITE ANTIDOTE.

Department of Defense · $9,407,618 · Jun 1, 2020

Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.

Search open bids